A validated gene regulatory network and GWAS identifies early regulators of T cell–associated diseases

Combining a gene regulatory network and disease association data identified early regulators of T cell–associated diseases. Identifying disease before it starts Diseases may be easier to treat if caught early. However, means of identifying early disease—especially before symptoms appear—are in short supply. Now, Gustafsson et al. identify early regulators of T cell–mediated disease by finding transcription factors involved in T cell differentiation that are enriched in disease-associated polymorphisms. Three such experimentally validated transcription factors—GATA3, MAF, and MYB—and their targets were found to be differentially expressed in asymptomatic stages of two different T cell–mediated diseases—multiple sclerosis and seasonal allergic rhinitis. These data not only provide potential markers of disease development but also shed light on the mechanistic underpinning of T cell–mediated disease. Early regulators of disease may increase understanding of disease mechanisms and serve as markers for presymptomatic diagnosis and treatment. However, early regulators are difficult to identify because patients generally present after they are symptomatic. We hypothesized that early regulators of T cell–associated diseases could be found by identifying upstream transcription factors (TFs) in T cell differentiation and by prioritizing hub TFs that were enriched for disease-associated polymorphisms. A gene regulatory network (GRN) was constructed by time series profiling of the transcriptomes and methylomes of human CD4+ T cells during in vitro differentiation into four helper T cell lineages, in combination with sequence-based TF binding predictions. The TFs GATA3, MAF, and MYB were identified as early regulators and validated by ChIP-seq (chromatin immunoprecipitation sequencing) and small interfering RNA knockdowns. Differential mRNA expression of the TFs and their targets in T cell–associated diseases supports their clinical relevance. To directly test if the TFs were altered early in disease, T cells from patients with two T cell–mediated diseases, multiple sclerosis and seasonal allergic rhinitis, were analyzed. Strikingly, the TFs were differentially expressed during asymptomatic stages of both diseases, whereas their targets showed altered expression during symptomatic stages. This analytical strategy to identify early regulators of disease by combining GRNs with genome-wide association studies may be generally applicable for functional and clinical studies of early disease development.

[1]  Mariano J. Alvarez,et al.  Identification of Causal Genetic Drivers of Human Disease through Systems-Level Analysis of Regulatory Networks , 2014, Cell.

[2]  Colm E. Nestor,et al.  Targeted omics and systems medicine: personalising care. , 2014, The Lancet. Respiratory medicine.

[3]  Erik L. L. Sonnhammer,et al.  Functional association networks as priors for gene regulatory network inference , 2014, Bioinform..

[4]  Mariano J. Alvarez,et al.  Cross-species regulatory network analysis identifies a synergistic interaction between FOXM1 and CENPF that drives prostate cancer malignancy. , 2014, Cancer cell.

[5]  Nathan D. Price,et al.  Demystifying Disease, Democratizing Health Care , 2014, Science Translational Medicine.

[6]  Colm E. Nestor,et al.  Integrated genomic and prospective clinical studies show the importance of modular pleiotropy for disease susceptibility, diagnosis and treatment , 2014, Genome Medicine.

[7]  Colm E. Nestor,et al.  A Generally Applicable Translational Strategy Identifies S100A4 as a Candidate Gene in Allergy , 2014, Science Translational Medicine.

[8]  Michael A. Langston,et al.  DNA Methylation Changes Separate Allergic Patients from Healthy Controls and May Reflect Altered CD4+ T-Cell Population Structure , 2014, PLoS genetics.

[9]  Yang Du,et al.  rSNPBase: a database for curated regulatory SNPs , 2013, Nucleic Acids Res..

[10]  Colm E. Nestor,et al.  Profiling of human CD4+ T-cell subsets identifies the TH2-specific noncoding RNA GATA3-AS1. , 2013, The Journal of allergy and clinical immunology.

[11]  M. Pirinen,et al.  Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis , 2013, Nature Genetics.

[12]  T. Takeuchi,et al.  CD247 variants and single-nucleotide polymorphisms observed in systemic lupus erythematosus patients. , 2013, Rheumatology.

[13]  J. Wetzels,et al.  Phospholipase A2 receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy. , 2013, Journal of the American Society of Nephrology : JASN.

[14]  Richard Bonneau,et al.  Robust data-driven incorporation of prior knowledge into the inference of dynamic regulatory networks , 2013, Bioinform..

[15]  B. Hedblad,et al.  T-Helper 2 Immunity Is Associated With Reduced Risk of Myocardial Infarction and Stroke , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[16]  Jorng-Tzong Horng,et al.  An enhanced computational platform for investigating the roles of regulatory RNA and for identifying functional RNA motifs , 2013, BMC Bioinformatics.

[17]  Remo Rohs,et al.  DNA binding by GATA transcription factor suggests mechanisms of DNA looping and long-range gene regulation. , 2012, Cell reports.

[18]  P. Libby,et al.  A guanidine-rich regulatory oligodeoxynucleotide improves type-2 diabetes in obese mice by blocking T-cell differentiation , 2012, EMBO molecular medicine.

[19]  M. Jarvelin,et al.  Highly interconnected genes in disease-specific networks are enriched for disease-associated polymorphisms , 2012, Genome Biology.

[20]  Steven L Salzberg,et al.  Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.

[21]  Graham M. Lord,et al.  T-bet and GATA3 orchestrate Th1 and Th2 differentiation through lineage-specific targeting of distal regulatory elements , 2012, Nature Communications.

[22]  Pak Chung Sham,et al.  GWASdb: a database for human genetic variants identified by genome-wide association studies , 2011, Nucleic Acids Res..

[23]  Hui Liu,et al.  AnimalTFDB: a comprehensive animal transcription factor database , 2011, Nucleic Acids Res..

[24]  Xuerui Yang,et al.  An Extensive MicroRNA-Mediated Network of RNA-RNA Interactions Regulates Established Oncogenic Pathways in Glioblastoma , 2011, Cell.

[25]  Simon C. Potter,et al.  Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis , 2011, Nature.

[26]  Torbjörn E. M. Nordling,et al.  Network modeling of the transcriptional effects of copy number aberrations in glioblastoma , 2011, Molecular systems biology.

[27]  Jason B. Ernst,et al.  Integrating multiple evidence sources to predict transcription factor binding in the human genome. , 2010, Genome research.

[28]  Trevor Hastie,et al.  Regularization Paths for Generalized Linear Models via Coordinate Descent. , 2010, Journal of statistical software.

[29]  Aaron R. Quinlan,et al.  Bioinformatics Applications Note Genome Analysis Bedtools: a Flexible Suite of Utilities for Comparing Genomic Features , 2022 .

[30]  Hui Wang,et al.  Increased IFN-gamma activity in seasonal allergic rhinitis is decreased by corticosteroid treatment. , 2009, The Journal of allergy and clinical immunology.

[31]  J. Gribben,et al.  Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts. , 2009, Blood.

[32]  C. Sotiriou,et al.  Molecular profiling of CD3-CD4+ T cells from patients with the lymphocytic variant of hypereosinophilic syndrome reveals targeting of growth control pathways. , 2009, Blood.

[33]  Marcel J. T. Reinders,et al.  Fewer permutations, more accurate P-values , 2009, Bioinform..

[34]  T. Waldmann,et al.  Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability. , 2009, Blood.

[35]  Jesper Tegnér,et al.  Reverse Engineering of Gene Networks with LASSO and Nonlinear Basis Functions , 2009, Annals of the New York Academy of Sciences.

[36]  Clifford A. Meyer,et al.  Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.

[37]  Stephen L. Hauser,et al.  Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event , 2008, Proceedings of the National Academy of Sciences.

[38]  Michael A Langston,et al.  A network-based analysis of the late-phase reaction of the skin. , 2006, The Journal of allergy and clinical immunology.

[39]  Richard Bonneau,et al.  The Inferelator: an algorithm for learning parsimonious regulatory networks from systems-biology data sets de novo , 2006, Genome Biology.

[40]  Ana Conesa,et al.  Gene expression maSigPro : a method to identify significantly differential expression profiles in time-course microarray experiments , 2006 .

[41]  J. Gribben,et al.  Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells. , 2005, The Journal of clinical investigation.

[42]  M. Gustafsson,et al.  Constructing and analyzing a large-scale gene-to-gene regulatory network Lasso-constrained inference and biological validation , 2005, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[43]  G. Salemi,et al.  Multiple Sclerosis Severity Score: Using disability and disease duration to rate disease severity , 2005, Neurology.

[44]  H. Zou,et al.  Regularization and variable selection via the elastic net , 2005 .

[45]  Chris Wiggins,et al.  ARACNE: An Algorithm for the Reconstruction of Gene Regulatory Networks in a Mammalian Cellular Context , 2004, BMC Bioinformatics.

[46]  C. Lowenstein,et al.  The Central Role of CD4+ T Cells in the Antitumor Immune Response , 1998, The Journal of experimental medicine.

[47]  T. Kanzaki,et al.  Late phase reaction of the skin , 1991 .

[48]  A. Popov,et al.  [C-terminal amidation of acylamino acids and peptides using a transpeptidation method catalyzed by carboxypeptidase Y]. , 1988, Bioorganicheskaia khimiia.